18 May 2013
Keywords: Osteologix, NB S101, Osteoporosis, Research, Servier, Protelos
Article | 21 October 2009
Marking its own progress and in recognition of World Osteoporosis Day, USA-based Osteologix says it will continue the clinical development ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 October 2009
22 October 2009
17 May 2013
© 2013 thepharmaletter.com